Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)

Detalles Bibliográficos
Autores principales: Qu, Fengjiang, Wu, Di, Liu, Yunjiang, Gao, Wei, Wang, Shu, Wang, Siyuan, Jin, Feng, Chen, Bo, Huang, Jian, Sun, Shanshan, Fan, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509065/
https://www.ncbi.nlm.nih.gov/pubmed/35970595
http://dx.doi.org/10.1097/CM9.0000000000002309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509065/
https://www.ncbi.nlm.nih.gov/pubmed/35970595
http://dx.doi.org/10.1097/CM9.0000000000002309

Ejemplares similares